Search results
Results from the WOW.Com Content Network
A 2012 review of cannabis use and dependency in the United States by Danovitch et al said that "42% of persons over age 12 have used cannabis at least once in their lifetime, 11.5% have used within the past year, and 1.8% have met diagnostic criteria for cannabis abuse or dependence within the past year. Among individuals who have ever used ...
The study, published in the journal JAMA Open Network, is the "largest of its kind," according to the university, using brain imaging technology to examine the effects of cannabis use on 1,000 ...
New research shows that heavy lifetime use of cannabis — more than 1,000 times — is associated with reduced activity in areas of the brain involved in working memory. The study adds to ...
Researchers found that 63% of lifetime heavy cannabis-using participants and 68% of recent cannabis users showed reduced brain activity during their working memory task.
A dried cannabis flower. The short-term effects of cannabis are caused by many chemical compounds in the cannabis plant, including 113 [clarification needed] different cannabinoids, such as tetrahydrocannabinol, and 120 terpenes, [1] which allow its drug to have various psychological and physiological effects on the human body.
Cannabis has many different names, including more than 1,200 slang terms, and more than 2,300 names for individual strains. [1] Additionally, there are many names to describe the state of being under the influence of the substance. [2] This list is not exhaustive; it includes well-attested names.
Acute necrotizing encephalopathy (ANE) or sometimes necrotizing encephalitis or infection-induced acute encephalopathy (IIAE) is a rare type of brain disease (encephalopathy) that occurs following a viral infection. [4] Most commonly, it develops secondary to infection with influenza A, influenza B, and the human herpes virus 6. ANE can be ...
There is emerging evidence that cannabidiol may help slow cell damage in diabetes mellitus type 1. [30] There is a lack of meaningful evidence of the effects of medical cannabis use on people with diabetes; a 2010 review concluded that "the potential risks and benefits for diabetic patients remain unquantified at the present time". [31]